<DOC>
	<DOCNO>NCT01024530</DOCNO>
	<brief_summary>The purpose study evaluate efficacy ex vivo expand autologous immune killer cell treat hepatocellular carcinoma patient in： 1 . Reduction tumor size 2 . Reducing relapse rate : Reducing frequency TACE treatment IKC injection .</brief_summary>
	<brief_title>Phase II/III Trial Hepatocellular Carcinoma Patients Treated ex Vivo Expanded Autologous Immune Killer Cells Adjunct Therapy</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>1 . Sign give write informed consent . 2 . Age≧20 year , but＜80 year . 3 . Hepatocellular carcinoma CT , MRI , AFP , angiography cytology/biopsy examination . 4 . Barcelona stag system stage B C. 5 . Never receive TACE treatment comply standard TACE treatment . 6 . ChildPugh stage A B . 7 . ECOG performance status 0 2 . 1 . Participant clinical trial within past 4 week screen period . 2 . Receiver chemotherapy , radiotherapy , immunotherapy , hormone therapy , local tumor therapy , target therapy within past 4 week screen period . 3 . Carriers HIV HTLV within past 4 week screen period . 4 . With Active acute chronic infection（by investigator 's judgement） . 5 . Other disease , except hepatocellular carcinoma , lifethreatening patients（by investigator 's judgement ) example : 5.1 Active cardiac disease require therapy coronary artery disease , congestive heart failure , arrhythmia myocardial infarction . 5.2 With previous history encephalopathy within past six month . 5.3 Involved Involving systemically known central nerve system diseases（brain meningeal metastasis） . 6 . Women pregnant breastfeed childbearing potential without adequate contraception .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>HCC</keyword>
	<keyword>NK</keyword>
	<keyword>immune killer cell</keyword>
</DOC>